Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A indicate strong financial performance, with significant improvements in EBITDA and net income, and optimistic guidance for 2026. The Q&A reveals a robust pipeline for MGAs and increased capacity, suggesting growth potential. Although guidance remains unchanged, the positive quarter performance and strategic initiatives, like AI integration, support a positive outlook. The lack of additional buy-ins and detailed plans for Everspan are minor concerns but do not outweigh the overall positive sentiment. Market reaction is likely positive, reflecting the strong financial metrics and strategic growth plans.
Total Revenue (Insurance Distribution Segment) $78.5 million in Q1 2026, a 92% increase year-over-year. This growth was driven by the acquisition of ArmadaCare in October 2025 and organic growth of 42%.
Adjusted EBITDA (Insurance Distribution Segment) $25.3 million in Q1 2026, nearly a fourfold increase from $7.1 million in Q1 2025. This was due to the acquisition of ArmadaCare, organic growth across MGAs, higher profit commissions, and lower interest expenses.
Net Income to Shareholders (Insurance Distribution Segment) $13.2 million in Q1 2026, compared to a net loss of $3.4 million in Q1 2025, an improvement of $16.6 million. This was driven by organic growth and the ArmadaCare acquisition.
Consolidated Adjusted EBITDA $20.1 million in Q1 2026, compared to negative $1.3 million in Q1 2025, representing a $21.4 million improvement. This was driven by the Insurance Distribution segment and lower corporate overhead.
Consolidated Adjusted Net Income to Shareholders $16.6 million or $0.37 per share in Q1 2026, compared to a net loss of $6 million or $0.13 per share in Q1 2025, an improvement of $22.6 million or $0.50 per share. This was due to improved performance in the Insurance Distribution segment.
Gross Premiums Written (Everspan) $104 million in Q1 2026, up 19% year-over-year. This increase was driven by the repositioning of the portfolio starting in late 2024.
Net Premiums Written (Everspan) $32 million in Q1 2026, up 80% year-over-year. This was due to the repositioning of the portfolio and the addition of new programs.
Net Premiums Earned (Everspan) $20 million in Q1 2026, up 28% year-over-year. This was driven by the repositioning of the portfolio and new programs.
Adjusted EBITDA (Everspan) $2 million in Q1 2026, up 2% year-over-year. This was due to expense reduction initiatives and portfolio repositioning.
Net Loss to Shareholders $6.9 million or $0.13 per share in Q1 2026, compared to a net loss of $16.1 million or $0.57 per share in Q1 2025, an improvement of 57%. This was driven by improved performance in the Insurance Distribution segment and lower corporate overhead.
New MGAs launched: 40% or 9 of the MGAs are new, launched in 2024 and 2025, contributing to early-stage growth.
AI and data strategy: Octave is pursuing AI through proprietary systems and partnerships, with Anthropic as the core AI solution, enhancing underwriting and operational capabilities.
Geographic diversification: Property-focused MGAs are diversified across the U.S., U.K., and Bermuda markets, focusing on low-CAT exposed lines and niche SME markets.
Casualty lines growth: Positive rate environment in higher hazard lines like transport and habitational, with rate increases above 10%.
Revenue growth: Insurance distribution business grew total revenues by 92%, driven by 42% organic growth and the acquisition of ArmadaCare.
Cost structure realignment: Significant strides in realigning cost structure to match the scale of the growing platform.
Expense reduction: Corporate expenses reduced to $12 million from $15 million, with adjusted expenses declining to $7.2 million from $10.6 million.
Strategic acquisitions: Acquired ArmadaCare in 2025 and Beat Capital Partners in 2024 to strengthen the platform.
Focus on organic growth: Organic growth is the primary driver, supported by product and geographic expansion, cross-sell opportunities, and enhanced carrier relationships.
Early-stage MGAs contributing negatively to adjusted EBITDA: 40% of the company's MGAs are new, launched in 2024 and 2025, and are still in early growth stages, with some contributing negatively to adjusted EBITDA.
Softening property lines market: Property lines are softening, particularly in large and middle market account segments and CAT-driven exposures, which could impact profitability.
Rate declines in property-focused MGAs: Property-focused MGAs are navigating rate declines and selectively underwriting risks, which may affect risk-adjusted returns.
Seasonality and variability in results: The company's results are subject to variability due to seasonality and other factors, such as the nature of de novo MGAs.
Settlement costs impacting Everspan: Everspan incurred losses and expenses related to a settlement to resolve potential litigation matters, which significantly impacted its loss ratio and financial performance.
High debt-to-EBITDA ratio: The insurance distribution business has a debt-to-EBITDA ratio of 3.2 times, which could pose financial risks.
Corporate expense reduction challenges: Efforts to reduce corporate expenses are ongoing, but achieving long-term goals remains a challenge.
Growth in Accident & Health (A&H) Segment: The A&H segment is expected to represent about 30% of production in 2026, driven by the acquisition of ArmadaCare and strong organic growth. The company anticipates capitalizing on secular trends such as the growth of self-funded employer health plans, leading to opportunities in employer stop-loss, employee benefits, and supplemental A&H businesses.
AI and Data Strategy: Octave is pursuing AI through proprietary systems and partnerships with providers like Anthropic. These initiatives aim to enhance underwriting, speed to market, and operational efficiency, positioning Octave as a data-rich and AI-powered MGA platform.
Market Trends in Property and Casualty Lines: Property lines are softening, particularly in large and middle market accounts and CAT-driven exposures. However, Octave's focus on low-CAT exposed lines and niche SME markets provides resilience. Casualty lines are experiencing positive rate environments, especially in higher hazard lines like transport and habitational, with rate increases often exceeding 10%. Niche professional and specialty portfolio companies are expected to grow in a stable rate environment.
Organic Growth and Margin Expansion: The company aims to drive growth and margin expansion through product and geographic diversification, cross-selling, enhanced carrier relationships, and leveraging a digital data infrastructure.
Everspan's Repositioning: Everspan is expected to deliver solid top-line and bottom-line results following portfolio rebalancing and expense reduction initiatives. The company targets a combined ratio of approximately 95% in the long term.
The selected topic was not discussed during the call.
The earnings call summary and Q&A indicate strong financial performance, with significant improvements in EBITDA and net income, and optimistic guidance for 2026. The Q&A reveals a robust pipeline for MGAs and increased capacity, suggesting growth potential. Although guidance remains unchanged, the positive quarter performance and strategic initiatives, like AI integration, support a positive outlook. The lack of additional buy-ins and detailed plans for Everspan are minor concerns but do not outweigh the overall positive sentiment. Market reaction is likely positive, reflecting the strong financial metrics and strategic growth plans.
The earnings call presents a mixed picture: strong revenue growth in insurance distribution and improved EBITDA, but higher net losses and G&A expenses raise concerns. The Q&A section shows cautious optimism about cash flow and profitability, though the softening market cycle and operational risks remain. The lack of a new partnership announcement or strong guidance tempers expectations, leading to a neutral sentiment overall. Without market cap data, the stock's reaction is uncertain, but the mixed signals suggest limited price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.